Warburg Pincus Buys International Technidyne For $55 Million

Private equity firm Warburg Pincus has acquired International Technidyne for $55 million in cash, and has merged the company with clinical diagnostics company Nexus Dx. International Technidyne, based in New Jersey, provides hemostasis management and point-of-care testing products. Nexus Dx is based in San Diego, Calif.

DealsNorth AmericaUSBriefs